openPR Logo
Press release

Lubiprostone Market Size, Share, Development by 2024

02-26-2019 02:48 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Global Info Research

Global Info Research offers a latest published report on Lubiprostone Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-lubiprostone-market_p103886.html
 
Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation.

Scope of the Report:
The global Lubiprostone market is valued at x million USD in 2018 and is expected to reach x million USD by the end of 2024, growing at a CAGR of x% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lubiprostone.
Europe also play important roles in global market, with market size of x million USD in 2019 and will be x million USD in 2024, with a CAGR of x%.
This report studies the Lubiprostone market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lubiprostone market by product type and applications/end industries.

Market Segment by Companies, this report covers
    Takeda Pharmaceuticals

Market Segment by Type, covers
    8 mcg Capsules
    24 mcg Capsules

Market Segment by Applications, can be divided into
    CIC and OIC
    IBS-C

For More Information On This Report, Please Visit @
https://www.globalinforesearch.com/global-lubiprostone-market_p103886.html

Key Reasons to Purchase:
• To gain insightful analyses of the market and have a comprehensive understanding of the Lubiprostone Market and its commercial landscape.
• Learn about the market strategies that are being adopted by your competitors and leading organizations.
• To understand the future outlook and prospects for Lubiprostone Market analysis and forecast 2019- 2025.

Customization Service of the Report :
Global Info Research provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.

Contact US :
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lubiprostone Market Size, Share, Development by 2024 here

News-ID: 1615433 • Views:

More Releases from Global Info Research

Global Heterocyclic Pigments Industry Chain Analysis Report 2025
Global Heterocyclic Pigments Industry Chain Analysis Report 2025
Global Info Research announces the release of the report "Global Heterocyclic Pigments Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides a detailed overview of the Heterocyclic Pigments market scenario, including a thorough analysis of the Heterocyclic Pigments market size, sales quantity, average price, revenue, gross margin and market share.The Heterocyclic Pigments report provides an in-depth analysis of the competitive landscape, manufacturer's profiles, regional and
Addition Type Liquid Silicone Rubber Market Report:By Key Players, Types, Application, Forecast to 2031
Addition Type Liquid Silicone Rubber Market Report:By Key Players, Types, Applic …
Global Info Research's report offers key insights into the recent developments in the global Addition Type Liquid Silicone Rubber market that would help strategic decisions. It also provides a complete analysis of the market size, share, and potential growth prospects. Additionally, an overview of recent major trends, technological advancements, and innovations within the market are also included. Our report further provides readers with comprehensive insights and actionable analysis on
Fluorine-Free Foams Market Share, Sales Volume, Price Analysis Report 2025
Fluorine-Free Foams Market Share, Sales Volume, Price Analysis Report 2025
On Oct 27, Global Info Research released "Global Fluorine-Free Foams Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report includes an overview of the development of the Fluorine-Free Foams industry chain, the market status of Fluorine-Free Foams Market, and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Fluorine-Free Foams. According to our (Global Info Research) latest
Water-resisting Admixtures Market Share, Sales Volume, Price Analysis Report 2025
Water-resisting Admixtures Market Share, Sales Volume, Price Analysis Report 202 …
"Global Water-resisting Admixtures Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031" is published by Global Info Research. It covers the key influencing factors of the Water-resisting Admixtures market, including Water-resisting Admixtures market share, price analysis, competitive landscape, market dynamics, consumer behavior, and technological impact, etc.At the same time, comprehensive data analysis is conducted by national and regional sales, corporate competition rankings, product types and applications. This report

All 5 Releases


More Releases for Lubiprostone

Lubiprostone Market Analysis Competitive Landscape and Future Growth Projections …
The Lubiprostone Market Report 2024 Market Size, Trends, and Global Forecast 2024-2032, a new report from the WGR, provides a comprehensive analysis of the competitive environment, investment opportunities, winning tactics, and evolving market trends. According to a WGR analysis, the Lubiprostone market trends will be valued at USD 8.75 (USD Billion) by the end of 2032. In addition, the report forecasts that between 2024 and 2032, the Lubiprostone market trends
Irritable Bowel Syndrome Treatment Market Projections: Reaching $2.01 Billion Gl …
Allied Market Research recently published a report, titled, "Irritable Bowel Syndrome Treatment Market by Type (IBS with Diarrhea (IBS-D), IBS with Constipation (IBS-C), and Mixed IBS (IBS-M), Product (Rifaximin, Eluxadoline, Lubiprostone, Linaclotide, and Others), and End User (Hospitals Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2019-2026". According to the report, the global irritable bowel syndrome treatment industry was pegged at $1.07 billion
Irritable Bowel Syndrome with Constipation (IBS-C) Drug Market is Anticipated to …
Irritable Bowel Syndrome with Constipation (IBS-C) Drug Market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to boost the market include the rise in the geriatric population, increase in the prevalence of gastrointestinal diseases such as constipation, the surge in level of stress, and unhealthy diet. Moreover, some other factors that are expected to fuel the market growth include an
Irritable Bowel Syndrome with Constipation (IBS-C) Drug Market Is Likely to Expe …
The global irritable bowel syndrome with constipation (IBS-C) drug market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to boost the market include the rise in the geriatric population, increase in the prevalence of gastrointestinal diseases such as constipation, the surge in level of stress, and unhealthy diet. Moreover, some other factors that are expected to fuel the market growth
Irritable Bowel Syndrome with Constipation (IBS-C) Drug Market Comprehensive Ins …
The global irritable bowel syndrome with constipation (IBS-C) drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to boost the market include the rise in the geriatric population, increase in the prevalence of gastrointestinal diseases such as constipation, the surge in level of stress, and unhealthy diet. Moreover, some other factors that are expected to fuel the market
Irritable Bowel Syndrome Treatment Market Industry Will Grow Steadily with Leadi …
Growing prevalence of irritable bowel syndrome associated with lifestyle factors, stress, and increasing number of options for the treatment are expected to be the major factors driving the growth of the global irritable bowel syndrome treatment market over the forecast period. Manufacturers are focusing on upgrading the available treatment options as well as developing new solutions for symptom specific irritable bowel syndrome. Allergan plc received the U.S. Food & Drug Administration